-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Iufr91bCglMKC+sQJ2lFNZxRym04Bno1mwOuRdX3m44T6FSPwBb3yvewe0YCf++A Mfu1UkP56YPZZXLvgKc6Ew== 0001144204-09-045535.txt : 20090825 0001144204-09-045535.hdr.sgml : 20090825 20090825150218 ACCESSION NUMBER: 0001144204-09-045535 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090821 FILED AS OF DATE: 20090825 DATE AS OF CHANGE: 20090825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAYWOOD GEORGE WEAVER CENTRAL INDEX KEY: 0001000514 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 091033905 MAIL ADDRESS: STREET 1: CARE OF CRONIN AND VRIS, LLP STREET 2: 380 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVI BIOPHARMA INC CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE SW COLUMBIA STREET 2: STE 1105 CITY: PORTLAND STATE: OR ZIP: 97258 BUSINESS PHONE: 5032270554 MAIL ADDRESS: STREET 1: ONE SW COLUMBIA STREET 2: SUITE 1105 CITY: PORTLAND STATE: OR ZIP: 97258 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 v159007_ex.xml X0303 4 2009-08-21 1 0000873303 AVI BIOPHARMA INC AVII 0001000514 HAYWOOD GEORGE WEAVER C/O MOOMJIAN, WAITE, WACTLAR & COLEMAN LLP, 100 JERICHO QUADRANGLE, SUITE 225 JERICHO NY 11753 0 0 0 1 See remarks below Common Stock 2009-08-21 4 P 0 450000 1.39 A 7783717 D Common Stock 2009-08-25 4 P 0 30000 1.35 A 7813717 D Common Stock 2009-08-25 4 P 0 400000 A 8213717 D Common Stock 1426953 I By Spouse Warrants (right to buy) 1.78 2009-08-25 4 P 0 400000 A 2010-02-25 2014-08-25 Common Stock 160000 400000 D The reported securities are included within 400,000 Units purchased by the Reporting Person for $1.42 per Unit. Each Unit consists of one share of common stock and one warrant to purchase 0.40 of a share of common stock of the Issuer. Due to dilution from public offering by Issuer, Mr. Haywood is no longer a 10% Owner. /s/ George W. Haywood 2009-08-25 -----END PRIVACY-ENHANCED MESSAGE-----